Brief: FDA Grants Medivir's MIV-711 Rare Pediatric Disease Designation

Medivir AB

25/04/2024 09:11

April 25 (Reuters) - Medivir AB  MEDIVIR.ST :
    * FDA GRANTS MEDIVIR'S MIV-711 RARE PEDIATRIC DISEASE
DESIGNATION
AND ORPHAN DRUG DESIGNATION FOR THE TREATMENT OF
LEGG-CALVÉ-PERTHES DISEASE

Source text for Eikon:  ID:nWkr9LNxxC 
Further company coverage:  MEDIVIR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))